Stock Events

Stock Events

BioXcel Therapeutics (BX20.F) Q2 2025 Earnings

12MayConfirmed

Q4 2024

Q1 2025

Q2 2025

-7.68

-5.57

-3.46

-1.35

Details

Expected EPS

-2.4511552

Actual EPS

-1.35174

Surprise EPS

1.1

Surprise Percent

+44.85%

Description

BioXcel Therapeutics (BX20.F) has reported earnings of -1.35174 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.